INCYTE CORPORATION Payments to Acquire Marketable Securities
INCYTE CORPORATION (INCY) reported Payments to Acquire Marketable Securities of $142.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-04-28
- INCYTE CORPORATION payments to acquire marketable securities for the quarter ending 2026-03-31 was $142.70M, a 246.06% increase year-over-year.
- INCYTE CORPORATION payments to acquire marketable securities for the quarter ending 2025-12-31 was $82.66M, a 181.29% increase year-over-year.
- INCYTE CORPORATION payments to acquire marketable securities for the quarter ending 2025-09-30 was $115.51M, a 363.97% increase year-over-year.
- INCYTE CORPORATION payments to acquire marketable securities for the quarter ending 2025-06-30 was $56.11M, a 46.57% increase year-over-year.
- INCYTE CORPORATION payments to acquire marketable securities for fiscal 2025 was $295.51M, a 14.37% increase from fiscal 2024.
- INCYTE CORPORATION payments to acquire marketable securities for fiscal 2024 was $258.37M, a 43.34% decline from fiscal 2023.
- INCYTE CORPORATION payments to acquire marketable securities for fiscal 2023 was $456.02M, a 471.02% increase from fiscal 2022.
- INCYTE CORPORATION payments to acquire marketable securities for fiscal 2022 was $79.86M, a 66.04% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-03-31 | $142.70M 10-Q · filed 2026-04-28 | $225.36M derived: sum of 2 quarters · filed 2026-04-28 | $340.86M derived: sum of 3 quarters · filed 2026-04-28 | $396.97M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $82.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $198.16M derived: sum of 2 quarters · filed 2026-02-10 | $254.27M derived: sum of 3 quarters · filed 2026-02-10 | $295.51M 10-K · filed 2026-02-10 |
| 2025-09-30 | $115.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $171.62M derived: sum of 2 quarters · filed 2025-10-28 | $212.85M 10-Q · filed 2025-10-28 | $242.24M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $56.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $97.35M 10-Q · filed 2025-07-29 | $126.73M derived: sum of 3 quarters · filed 2026-04-28 | $151.63M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $41.24M 10-Q · filed 2026-04-28 | $70.62M derived: sum of 2 quarters · filed 2026-04-28 | $95.52M derived: sum of 3 quarters · filed 2026-04-28 | $133.80M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $29.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $54.28M derived: sum of 2 quarters · filed 2026-02-10 | $92.56M derived: sum of 3 quarters · filed 2026-02-10 | $258.37M 10-K · filed 2026-02-10 |
| 2024-09-30 | $24.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $63.18M derived: sum of 2 quarters · filed 2025-10-28 | $228.99M 10-Q · filed 2025-10-28 | $462.78M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $38.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $204.09M 10-Q · filed 2025-07-29 | $437.88M derived: sum of 3 quarters · filed 2026-02-10 | $507.83M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $165.81M 10-Q · filed 2025-04-29 | $399.60M derived: sum of 2 quarters · filed 2026-02-10 | $469.55M derived: sum of 3 quarters · filed 2026-02-10 | $566.94M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $233.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $303.74M derived: sum of 2 quarters · filed 2026-02-10 | $401.13M derived: sum of 3 quarters · filed 2026-02-10 | $456.02M 10-K · filed 2026-02-10 |
| 2023-09-30 | $69.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $167.34M derived: sum of 2 quarters · filed 2024-10-29 | $222.23M 10-Q · filed 2024-10-29 | $243.03M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $97.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $152.28M 10-Q · filed 2024-07-30 | $173.08M derived: sum of 3 quarters · filed 2025-02-10 | $188.15M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $54.89M 10-Q · filed 2024-04-30 | $75.69M derived: sum of 2 quarters · filed 2025-02-10 | $90.76M derived: sum of 3 quarters · filed 2025-02-10 | $134.75M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $20.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $35.87M derived: sum of 2 quarters · filed 2025-02-10 | $79.86M derived: sum of 3 quarters · filed 2025-02-10 | $79.86M 10-K · filed 2025-02-10 |
| 2022-09-30 | $15.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $59.06M derived: sum of 2 quarters · filed 2023-10-31 | $59.06M 10-Q · filed 2023-10-31 | $66.06M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $43.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $43.99M 10-Q · filed 2023-08-01 | $50.98M derived: sum of 3 quarters · filed 2024-02-13 | $176.87M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 | $7.00M derived: sum of 2 quarters · filed 2024-02-13 | $132.88M derived: sum of 3 quarters · filed 2024-02-13 | $195.87M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $132.88M derived: sum of 2 quarters · filed 2024-02-13 | $195.87M derived: sum of 3 quarters · filed 2024-02-13 | $235.17M 10-K · filed 2024-02-13 |
| 2021-09-30 | $125.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $188.87M derived: sum of 2 quarters · filed 2022-11-01 | $228.17M 10-Q · filed 2022-11-01 | $326.35M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $62.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $102.29M 10-Q · filed 2022-08-02 | $200.46M derived: sum of 3 quarters · filed 2023-02-07 | $331.74M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $39.30M 10-Q · filed 2022-05-03 | $137.48M derived: sum of 2 quarters · filed 2023-02-07 | $268.76M derived: sum of 3 quarters · filed 2023-02-07 | $408.77M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $98.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $229.46M derived: sum of 2 quarters · filed 2023-02-07 | $369.47M derived: sum of 3 quarters · filed 2023-02-07 | $516.87M 10-K · filed 2023-02-07 |
| 2020-09-30 | $131.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $271.30M derived: sum of 2 quarters · filed 2021-11-02 | $418.70M 10-Q · filed 2021-11-02 | $571.35M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $140.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $287.42M 10-Q · filed 2021-08-03 | $440.07M derived: sum of 3 quarters · filed 2022-02-08 | $558.26M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $147.40M 10-Q · filed 2021-05-04 | $300.06M derived: sum of 2 quarters · filed 2022-02-08 | $418.24M derived: sum of 3 quarters · filed 2022-02-08 | $487.64M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $152.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $270.84M derived: sum of 2 quarters · filed 2022-02-08 | $340.24M derived: sum of 3 quarters · filed 2022-02-08 | $374.81M 10-K · filed 2022-02-08 |
| 2019-09-30 | $118.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $187.58M derived: sum of 2 quarters · filed 2020-11-05 | $222.16M 10-Q · filed 2020-11-05 | $277.86M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $69.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $103.97M 10-Q · filed 2020-08-04 | $159.67M derived: sum of 3 quarters · filed 2021-02-09 | $205.07M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $34.57M 10-Q · filed 2020-05-05 | $90.28M derived: sum of 2 quarters · filed 2021-02-09 | $135.68M derived: sum of 3 quarters · filed 2021-02-09 | $156.47M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $55.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $101.11M derived: sum of 2 quarters · filed 2021-02-09 | $121.90M derived: sum of 3 quarters · filed 2021-02-09 | $159.93M 10-K · filed 2021-02-09 |
| 2018-09-30 | $45.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $66.19M derived: sum of 2 quarters · filed 2019-10-29 | $104.23M 10-Q · filed 2019-10-29 | $233.09M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $20.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $58.83M 10-Q · filed 2019-07-30 | $187.69M derived: sum of 3 quarters · filed 2020-02-13 | $204.35M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $38.03M 10-Q · filed 2019-04-30 | $166.89M derived: sum of 2 quarters · filed 2020-02-13 | $183.56M derived: sum of 3 quarters · filed 2020-02-13 | $192.54M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $128.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $145.53M derived: sum of 2 quarters · filed 2020-02-13 | $154.51M derived: sum of 3 quarters · filed 2020-02-13 | $260.78M 10-K · filed 2020-02-13 |
| 2017-09-30 | $16.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $25.65M derived: sum of 2 quarters · filed 2018-10-30 | $131.92M 10-Q · filed 2018-10-30 | $162.37M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $8.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $115.25M 10-Q · filed 2018-07-31 | $145.71M derived: sum of 3 quarters · filed 2019-02-14 | $154.83M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $106.27M 10-Q · filed 2018-05-01 | $136.72M derived: sum of 2 quarters · filed 2019-02-14 | $145.85M derived: sum of 3 quarters · filed 2019-02-14 | $146.85M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $30.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $39.58M derived: sum of 2 quarters · filed 2019-02-14 | $40.58M derived: sum of 3 quarters · filed 2019-02-14 | $57.37M 10-K · filed 2019-02-14 |
| 2016-09-30 | $9.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $10.13M derived: sum of 2 quarters · filed 2017-10-31 | $26.92M 10-Q · filed 2017-10-31 | $40.70M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $17.80M 10-Q · filed 2017-08-01 | $31.57M derived: sum of 3 quarters · filed 2018-02-15 | $45.73M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $16.80M 10-Q · filed 2017-05-04 | $30.57M derived: sum of 2 quarters · filed 2018-02-15 | $44.73M derived: sum of 3 quarters · filed 2018-02-15 | $90.48M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $13.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $27.94M derived: sum of 2 quarters · filed 2018-02-15 | $73.69M derived: sum of 3 quarters · filed 2018-02-15 | $108.15M 10-K · filed 2018-02-15 |
| 2015-09-30 | $14.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $59.91M derived: sum of 2 quarters · filed 2016-11-01 | $94.38M 10-Q · filed 2016-11-01 | $115.19M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $45.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $80.21M 10-Q · filed 2016-08-09 | $101.02M derived: sum of 3 quarters · filed 2017-02-14 | $149.19M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $34.47M 10-Q · filed 2016-05-09 | $55.28M derived: sum of 2 quarters · filed 2017-02-14 | $103.44M derived: sum of 3 quarters · filed 2017-02-14 | $123.44M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $20.81M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $68.98M derived: sum of 2 quarters · filed 2017-02-14 | $88.98M derived: sum of 3 quarters · filed 2017-02-14 | $134.09M 10-K · filed 2017-02-14 |
| 2014-09-30 | $48.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $68.17M derived: sum of 2 quarters · filed 2015-11-03 | $113.28M 10-Q · filed 2015-11-03 | $131.97M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $65.11M 10-Q · filed 2015-08-04 | $83.80M derived: sum of 3 quarters · filed 2016-02-12 | $83.82M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $45.11M 10-Q · filed 2015-04-30 | $63.80M derived: sum of 2 quarters · filed 2016-02-12 | $63.82M derived: sum of 3 quarters · filed 2016-02-12 | $78.96M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $18.69M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $18.70M derived: sum of 2 quarters · filed 2016-02-12 | $33.85M derived: sum of 3 quarters · filed 2016-02-12 | $33.71M 10-K · filed 2016-02-12 |
| 2013-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $15.16M derived: sum of 2 quarters · filed 2014-10-30 | $15.02M 10-Q · filed 2014-10-30 | |
| 2013-06-30 | $15.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $15.01M 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | -$136.00K 10-Q · filed 2014-05-01 | |||
| 2012-12-31 | -$860.00K 10-K · filed 2015-02-17 | |||
| 2011-12-31 | -$1.30M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |